Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis
Value in Health · 2025
DOI: 10.1016/j.jval.2024.05.017 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Value in Health, 2025. Verfasst von Julia F Slejko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Patient-Driven Values in Healthcare Evaluation (PAVE) Center, Department of Practice, Sciences and Health Outcomes Research, University of Maryland S…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Cost-Benefit Analysis, Patient Participation, Antidepressive Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVES: Prior work identified 6 key value elements (attributes of treatment and desired outcomes) for individuals living with major depressive disorder (MDD) in managing their condition: mode of treatment, time to treatment helpfulness, MDD relief, quality of work, interaction with others, and affordability. The objective of our study was to identify whether previous cost-effectiveness analyses (CEAs) for MDD treatment addressed any of these value elements. A secondary objective was to identify whether any study engaged patients, family members, and caregivers in the model development process. METHODS: We conducted a systematic literature review to identify published model-based CEAs. We compared the elements of the published studies with the MDD patient value elements elicited in prior work to identify gaps and areas for future research. RESULTS: Of 86 published CEAs, we found that 7 included patient out-of-pocket costs, and 32 included measures of productivity, which were both priorities for individuals with MDD. We found that only 2 studies elicited measures from patients for their model, and 2 studies engaged patients in the modeling process. CONCLUSIONS: Published CEA models for MDD treatment do not regularly include value elements that are a priority for this patient population nor do they include patients in their modeling process. Flexible models that can accommodate elements consistent with patient experience are needed, and a multistakeholder engagement approach would help accomplish this.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Patient-Driven Values in Healthcare Evaluation (PAVE) Center, Department of Practice, Sciences and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, MD, USA. Electronic address: jslejko@rx.…
- Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA.
- Patient-Driven Values in Healthcare Evaluation (PAVE) Center, Department of Practice, Sciences and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, MD, USA.
- Innovation and Value Initiative, Alexandria, VA, USA.
Zitieren
APA
Slejko, J. F., Mattingly, T. J., Wilson, A., Xie, R., Chapman, R. H., Amill-Rosario, A., & dosReis, S. (2025). Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis. Value in Health. https://doi.org/10.1016/j.jval.2024.05.017
Vancouver
Slejko JF, Mattingly TJ, Wilson A, Xie R, Chapman RH, Amill-Rosario A, et al. Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis. Value in Health. 2025. doi:10.1016/j.jval.2024.05.017
BibTeX
@article{Slejko2025,
author = {Slejko, Julia F and Mattingly, T Joseph and Wilson, Alexandra and Xie, Richard and Chapman, Richard H and Amill-Rosario, Alejandro and dosReis, Susan},
title = {Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis},
journal = {Value in Health},
year = {2025},
doi = {10.1016/j.jval.2024.05.017}
}
EUVIMED